Targeting CAFs and extracellular matrix (ECM) in lung cancer: Potential of adjuvants and nanoparticles
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cancer-associated fibroblasts (CAFs) and the extracellular matrix (ECM) drive lung cancer growth and metastasis. Targeting CAFs and ECM remodeling offers new therapeutic strategies for lung cancer treatment.
Area Of Science
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background
- Cancer-associated fibroblasts (CAFs) are key components of the lung tumor stroma, promoting tumor progression via extracellular matrix (ECM) remodeling.
- The tumor ECM in lung cancer influences cancer cell proliferation, drug penetration, immune response, and therapeutic resistance.
Purpose Of The Study
- To review the critical roles of CAFs and the ECM in lung cancer initiation and progression.
- To explore therapeutic strategies involving adjuvants, phytochemicals, and nanoparticles for modulating CAFs and ECM in lung tumors.
Main Methods
- Literature review of studies on CAFs and ECM in lung cancer.
- Analysis of the interplay between CAFs, ECM, and lung tumorigenesis.
- Evaluation of potential therapeutic interventions targeting CAF-ECM interactions.
Main Results
- CAFs significantly contribute to lung cancer growth, invasion, and metastasis through ECM remodeling.
- Altered ECM composition and organization in lung cancer impact treatment efficacy and resistance.
- Targeting the CAF-ECM axis presents a promising avenue for novel lung cancer therapies.
Conclusions
- Understanding the complex interactions between CAFs and the ECM is vital for advancing lung cancer treatment.
- Modulating CAF functions and ECM remodeling holds potential for overcoming therapeutic challenges in lung cancer.
- Adjuvants, phytochemicals, and nanoparticles show promise as therapeutic agents in targeting the lung tumor microenvironment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...